Radiopharmaceutical · Acts on mitochondrial complex 1 (MC-1) · developed by Lantheus Medical Imaging
Fluorine F 18 flurpiridaz is a radioconjugate, an analog of the mitochondrial complex 1 inhibitor pyridaben labeled with fluorine F 18, used for PET myocardial perfusion imaging. It binds mitochondrial complex 1 in biologically active mitochondria, which are denser in cardiac muscle, and its extraction is proportional to blood flow, so infarcted tissue shows lower radioactivity. It is studied in healthy subjects and in coronary artery disease.
Summary written with AI from the sources listed at the end of this page.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT01347710 | Phase 3 | Coronary Artery Disease | Completed | LNTH |
| NCT00707499 | Phase 1 | Healthy | Completed | LNTH |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Coronary Artery DiseaseHealthy
Updated Nov 15, 2026. Something wrong or missing? Report it on the LNTH page.
See LNTH's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
LNTH catalysts and pipeline →